JP2023531935A5 - - Google Patents
Info
- Publication number
- JP2023531935A5 JP2023531935A5 JP2022579077A JP2022579077A JP2023531935A5 JP 2023531935 A5 JP2023531935 A5 JP 2023531935A5 JP 2022579077 A JP2022579077 A JP 2022579077A JP 2022579077 A JP2022579077 A JP 2022579077A JP 2023531935 A5 JP2023531935 A5 JP 2023531935A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- complement
- position corresponding
- sequence
- positions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042327P | 2020-06-22 | 2020-06-22 | |
| US63/042,327 | 2020-06-22 | ||
| US202063066185P | 2020-08-15 | 2020-08-15 | |
| US63/066,185 | 2020-08-15 | ||
| US202063075858P | 2020-09-09 | 2020-09-09 | |
| US63/075,858 | 2020-09-09 | ||
| US202063089625P | 2020-10-09 | 2020-10-09 | |
| US63/089,625 | 2020-10-09 | ||
| US202063104613P | 2020-10-23 | 2020-10-23 | |
| US63/104,613 | 2020-10-23 | ||
| US202163142632P | 2021-01-28 | 2021-01-28 | |
| US63/142,632 | 2021-01-28 | ||
| US202163159017P | 2021-03-10 | 2021-03-10 | |
| US63/159,017 | 2021-03-10 | ||
| US202163210287P | 2021-06-14 | 2021-06-14 | |
| US63/210,287 | 2021-06-14 | ||
| US202163211061P | 2021-06-16 | 2021-06-16 | |
| US63/211,061 | 2021-06-16 | ||
| PCT/US2021/038260 WO2021262601A1 (en) | 2020-06-22 | 2021-06-21 | Treatment of obesity with g-protein coupled receptor 75 (gpr75) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531935A JP2023531935A (ja) | 2023-07-26 |
| JP2023531935A5 true JP2023531935A5 (https=) | 2024-06-20 |
Family
ID=76943116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579077A Pending JP2023531935A (ja) | 2020-06-22 | 2021-06-21 | Ｇタンパク質共役受容体７５（ｇｐｒ７５）阻害剤による肥満の治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11359246B2 (https=) |
| EP (1) | EP4168548A1 (https=) |
| JP (1) | JP2023531935A (https=) |
| KR (1) | KR20230041709A (https=) |
| CN (1) | CN116249787A (https=) |
| AU (1) | AU2021296270A1 (https=) |
| CA (1) | CA3186576A1 (https=) |
| IL (1) | IL298930A (https=) |
| MX (1) | MX2022016458A (https=) |
| WO (1) | WO2021262601A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11359246B2 (en) * | 2020-06-22 | 2022-06-14 | Regeneron Pharmaceuticals, Inc. | Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors |
| EP4225917A1 (en) * | 2020-10-05 | 2023-08-16 | Alnylam Pharmaceuticals, Inc. | G protein-coupled receptor 75 (gpr75) irna compositions and methods of use thereof |
| US20250367321A1 (en) * | 2022-06-24 | 2025-12-04 | The Regents Of The University Of California | Compositions and methods involving adgrg6 |
| WO2025176787A1 (en) | 2024-02-22 | 2025-08-28 | Orion Biotechnology Holding Sa | Ccl5 variants for modulating gpr75 |
| CN120624452B (zh) * | 2025-08-12 | 2025-11-14 | 苏州吉玛基因股份有限公司 | 一种抑制GPR75基因表达的siRNA及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005040790A2 (en) * | 2003-10-24 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) |
| US20080108145A1 (en) | 2006-11-07 | 2008-05-08 | Stephanie Chissoe | Genes associated with osteoarthritis |
| US20080108080A1 (en) * | 2006-11-07 | 2008-05-08 | Stephanie Chissoe | Genes associated with obesity |
| EP1961825A1 (en) | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Method for predicting the occurrence of metastasis in breast cancer patients |
| US10446261B1 (en) | 2008-01-06 | 2019-10-15 | Biotailor, Inc. | System and method for analyzing splicing codes of spliceosomal introns |
| US8185323B1 (en) | 2008-01-06 | 2012-05-22 | Degen Zhuo | Method of identifying exons and introns and diagnostic uses thereof |
| US20110177964A1 (en) | 2009-12-03 | 2011-07-21 | The Trustees Of Princeton University | Chemosensory arrays |
| EP2763540A4 (en) * | 2011-09-09 | 2015-04-22 | Univ Yale | COMPOSITIONS AND METHODS FOR THE EVALUATION AND TREATMENT OF INFLAMMATORY DISEASES AND DISEASES |
| US20140377278A1 (en) | 2012-01-10 | 2014-12-25 | Yale University | Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders |
| WO2015017656A1 (en) | 2013-07-31 | 2015-02-05 | The Regents Of The University Of California | Methods of diagnosis and treatment for pulmonary arterial hypertension |
| WO2017004153A1 (en) | 2015-06-29 | 2017-01-05 | The Broad Institute Inc. | Tumor and microenvironment gene expression, compositions of matter and methods of use thereof |
| US20230000912A1 (en) | 2016-01-25 | 2023-01-05 | The Broad Institute, Inc. | Genetic, developmental and micro-environmental programs in idh-mutant gliomas, compositions of matter and methods of use thereof |
| US11690825B2 (en) * | 2016-03-09 | 2023-07-04 | Board Of Regents, The University Of Texas System | 20-HETE receptor (GPR75) antagonists and methods of use |
| WO2017176672A1 (en) | 2016-04-04 | 2017-10-12 | The Regents Of The University Of California | Compositions and methods related to polycytotoxic t cells |
| WO2017191274A2 (en) | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| CN118108847A (zh) | 2016-08-07 | 2024-05-31 | 诺华股份有限公司 | mRNA介导的免疫方法 |
| US20200113950A1 (en) | 2017-06-30 | 2020-04-16 | The Rockefeller University | Human microbiota derived N-acyl amides for the treatment of human disease |
| WO2019036753A1 (en) | 2017-08-22 | 2019-02-28 | Monash University | SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE) |
| WO2019140380A1 (en) | 2018-01-12 | 2019-07-18 | Kymera Therapeutics, Inc. | Protein degraders and uses thereof |
| WO2020118363A1 (en) | 2018-12-10 | 2020-06-18 | Monash University | Screening assays, modulators and modulation of intracellular signalling mediated by immunoglobulin superfamily cell adhesion molecules |
| WO2020247220A1 (en) | 2019-06-03 | 2020-12-10 | University Of Florida Research Foundation, Inc. | Compositions and methods for predicting susceptibility of cancers to synthetic-lethal therapies |
| US11359246B2 (en) * | 2020-06-22 | 2022-06-14 | Regeneron Pharmaceuticals, Inc. | Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors |
-
2021
- 2021-06-21 US US17/353,313 patent/US11359246B2/en active Active
- 2021-06-21 AU AU2021296270A patent/AU2021296270A1/en active Pending
- 2021-06-21 EP EP21742592.5A patent/EP4168548A1/en active Pending
- 2021-06-21 KR KR1020237002641A patent/KR20230041709A/ko active Pending
- 2021-06-21 MX MX2022016458A patent/MX2022016458A/es unknown
- 2021-06-21 JP JP2022579077A patent/JP2023531935A/ja active Pending
- 2021-06-21 WO PCT/US2021/038260 patent/WO2021262601A1/en not_active Ceased
- 2021-06-21 IL IL298930A patent/IL298930A/en unknown
- 2021-06-21 CN CN202180051355.1A patent/CN116249787A/zh active Pending
- 2021-06-21 CA CA3186576A patent/CA3186576A1/en active Pending
-
2022
- 2022-05-19 US US17/748,110 patent/US20220411870A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531935A5 (https=) | ||
| KR101770435B1 (ko) | 자연 안티센스 전사체가 아포리포단백질-ａ1로 억제에 의해 아포리포단백-ａ1 관련된 질환의 치료 | |
| CN103301475B (zh) | 药物组合物和表达载体以及调节基因表达的方法和核酸分子的应用 | |
| EP1478772A2 (en) | Nucleic acid and amino acid sequences involved in pain | |
| JP2022523301A5 (https=) | ||
| JP2006517092A (ja) | 心不全遺伝子の決定及び治療薬スクリーニング | |
| van HILLE et al. | Heterogeneity of vacuolar H+-ATPase: differential expression of two human subunit B isoforms | |
| JP2009539960A (ja) | 加齢黄斑変性に対する保護および処置 | |
| JP2023531935A (ja) | Ｇタンパク質共役受容体７５（ｇｐｒ７５）阻害剤による肥満の治療 | |
| JP2023539742A5 (https=) | ||
| JP2022525545A5 (https=) | ||
| CN113727732B (zh) | 用固醇调节元件结合转录因子1(srebf1)抑制剂治疗脂质水平升高 | |
| JP2023524824A (ja) | Ｋｅｌｃｈドメイン含有７Ｂ（ＫＬＨＤＣ７Ｂ）バリアント及びその使用 | |
| JP2022515838A5 (https=) | ||
| JP2024522148A5 (https=) | ||
| JP2022525546A5 (https=) | ||
| JP2024536491A5 (https=) | ||
| JP2024535110A5 (https=) | ||
| JP2022525456A5 (https=) | ||
| US20260085319A1 (en) | Compositions for use in the treatment of chd2 haploinsufficiency | |
| US6797472B1 (en) | Variation in drug response related to polymorphisms in β2-adrenergic receptor | |
| JP2024508824A5 (https=) | ||
| JP2024521754A5 (https=) | ||
| CN108251519B (zh) | 轴前多指病的致病基因及其用途 | |
| CN107604065B (zh) | 一种肝癌miRNA标记物 |